Please login to the form below

Not currently logged in
Email:
Password:

Japanese pharmacos aid earthquake efforts

Several Japanese pharma companies have offered donations of both money and medical supplies to help with aid efforts following the Tohoku earthquake

Several Japanese pharma companies have offered donations of both money and medical supplies to help with aid efforts following the Tohoku earthquake.

The earthquake, which triggered tsunamis across Japan's eastern coastline, has killed at least 1,600 people, with thousands missing and many more left without homes.

Takeda Pharmaceutical has said it will donate 300m Japanese Yen (about £2.3m) to the Japanese Red Cross Society to help the emergency relief fund. Donations of pharmaceutical products have also been offered by the Osaka-based company.

Daiichi Sankyo also announced it would make a donation to the Japanese Red Cross worth 100m Japanese Yen (about £760,000), as well as implementing a programme to match donations made by its employees. The company also said it is looking to donate medical supplies to affected areas.

Other companies to offer donations to the Japanese Red Cross include Astellas (100m Japanese Yen); Chugai Pharmaceutical (100m Japanese Yen); and Eisai (200m Japanese Yen – about £1.5m).

Eisai also said it is to establish a crisis centre in the Tohoku region to help implement ongoing support in the affected areas.

To donate to the fund, visit the Red Cross Japan Tsunami Appeal.

14th March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics